VanEck Associates’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $658K | Buy |
438,645
+278,549
| +174% | +$355K | ﹤0.01% | 1196 |
|
|
2026
Q1 | $183K | Buy |
160,096
+23,077
| +17% | +$28.4K | ﹤0.01% | 1269 |
|
|
2025
Q4 | $173K | Buy |
137,019
+25,193
| +23% | +$35.1K | ﹤0.01% | 1295 |
|
|
2025
Q3 | $173K | Sell |
111,826
-7,215
| -6% | -$9.91K | ﹤0.01% | 1289 |
|
|
2025
Q2 | $157K | Buy |
119,041
+5,535
| +5% | +$7.57K | ﹤0.01% | 1274 |
|
|
2025
Q1 | $188K | Buy |
113,506
+6,722
| +6% | +$11.1K | ﹤0.01% | 1240 |
|
|
2024
Q4 | $157K | Sell |
106,784
-597
| -0.6% | -$913 | ﹤0.01% | 1246 |
|
|
2024
Q3 | $157K | Buy |
107,381
+1,665
| +2% | +$2.47K | ﹤0.01% | 1216 |
|
|
2024
Q2 | $132K | Sell |
105,716
-33,447
| -24% | -$43.4K | ﹤0.01% | 1233 |
|
|
2024
Q1 | $167K | Buy |
139,163
+6,228
| +5% | +$6.23K | ﹤0.01% | 1198 |
|
|
2023
Q4 | $201K | Sell |
132,935
-17,836
| -12% | -$25.8K | ﹤0.01% | 1168 |
|
|
2023
Q3 | $241K | Buy |
150,771
+9,591
| +7% | +$17.5K | ﹤0.01% | 1130 |
|
|
2023
Q2 | $306K | Sell |
141,180
-991
| -0.7% | -$1.55K | ﹤0.01% | 1120 |
|
|
2023
Q1 | $208K | Sell |
142,171
-1,993
| -1% | -$2.56K | ﹤0.01% | 1160 |
|
|
2022
Q4 | $180K | Buy |
144,164
+2,229
| +2% | +$3.51K | ﹤0.01% | 1125 |
|
|
2022
Q3 | $268K | Sell |
141,935
-17,744
| -11% | -$41.9K | ﹤0.01% | 984 |
|
|
2022
Q2 | $404K | Buy |
+159,679
| New | +$466K | ﹤0.01% | 949 |
|
|
2018
Q4 | – | Sell |
-96,668
| Closed | -$334K | – | 842 |
|
|
2018
Q3 | $334K | Sell |
96,668
-384
| -0.4% | -$2.04K | ﹤0.01% | 700 |
|
|
2018
Q2 | $456K | Sell |
97,052
-2,274
| -2% | -$8.63K | ﹤0.01% | 682 |
|
|
2018
Q1 | $315K | Buy |
99,326
+6,370
| +7% | +$25.6K | ﹤0.01% | 608 |
|
|
2017
Q4 | $455K | Sell |
92,956
-11,795
| -11% | -$68.4K | ﹤0.01% | 573 |
|
|
2017
Q3 | $719K | Buy |
104,751
+4,283
| +4% | +$27K | ﹤0.01% | 521 |
|
|
2017
Q2 | $661K | Buy |
100,468
+16,484
| +20% | +$116K | ﹤0.01% | 531 |
|
|
2017
Q1 | $672K | Buy |
83,984
+1,274
| +2% | +$10.7K | ﹤0.01% | 551 |
|
|
2016
Q4 | $769K | Sell |
82,710
-10,150
| -11% | -$105K | ﹤0.01% | 514 |
|
|
2016
Q3 | $983K | Buy |
92,860
+593
| +0.6% | +$5.91K | ﹤0.01% | 495 |
|
|
2016
Q2 | $862K | Sell |
92,267
-5,328
| -5% | -$54.1K | ﹤0.01% | 486 |
|
|
2016
Q1 | $1.01M | Buy |
97,595
+3,389
| +4% | +$31K | 0.01% | 446 |
|
|
2015
Q4 | $947K | Buy |
94,206
+9,927
| +12% | +$99.5K | 0.01% | 398 |
|
|
2015
Q3 | $709K | Buy |
84,279
+10,767
| +15% | +$143K | 0.01% | 423 |
|
|
2015
Q2 | $1.18M | Buy |
73,512
+10,584
| +17% | +$165K | 0.01% | 405 |
|
|
2015
Q1 | $892K | Sell |
62,928
-4,503
| -7% | -$58.6K | 0.01% | 427 |
|
|
2014
Q4 | $674K | Sell |
67,431
-2,620
| -4% | -$22.4K | ﹤0.01% | 441 |
|
|
2014
Q3 | $596K | Buy |
70,051
+6,510
| +10% | +$57.2K | ﹤0.01% | 460 |
|
|
2014
Q2 | $562K | Buy |
63,541
+253
| +0.4% | +$2.21K | ﹤0.01% | 471 |
|
|
2014
Q1 | $590K | Buy |
63,288
+13,131
| +26% | +$115K | ﹤0.01% | 426 |
|
|
2013
Q4 | $423K | Buy |
50,157
+35,827
| +250% | +$362K | ﹤0.01% | 470 |
|
|
2013
Q3 | $126K | Buy |
+14,330
| New | +$115K | ﹤0.01% | 583 |
|
Other funds holding OPK
RCMNY
WCM
VanEck Associates's OPK Position: Q2 2026 in Review
VanEck Associates increased its Opko Health (OPK) stake by 174% in Q2 2026, buying an estimated $355K and bringing the position to 438,645 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #1196.
VanEck Associates first reported a position in OPK in Q3 2013 and has held it in 38 quarters since. The position peaked at $1.18M in Q2 2015. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- VanEck Associates held 438,645 shares of Opko Health worth $658K as of Q2 2026.
- VanEck Associates bought 278,549 Opko Health shares in Q2 2026, an estimated $355K.
- Opko Health made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1196 holding.
- VanEck Associates first reported a position in Opko Health in Q3 2013 and has held it in 38 quarters since.
- VanEck Associates's Opko Health position peaked at $1.18M in Q2 2015.
- 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.